menu
    • menu

    Company profile for Senhwa Biosciences

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Senhwa Biosciences Inc. was established in 2012 and aims to transform the model for new drug development by focusing on human efficacy. Senhwa believes that its dedication to science and rigorous processes will make Senhwa achieve a remarkable milestone. Senhwa has a strong Management Team with proven track records in developing new drugs and targeted agents. Headquartered in Taiwan, but with a vital operational base in San Di...
    Senhwa Biosciences Inc. was established in 2012 and aims to transform the model for new drug development by focusing on human efficacy. Senhwa believes that its dedication to science and rigorous processes will make Senhwa achieve a remarkable milestone. Senhwa has a strong Management Team with proven track records in developing new drugs and targeted agents. Headquartered in Taiwan, but with a vital operational base in San Diego, California, the Senhwa Team is well positioned to oversee the development of their compounds by collaborating with a diverse range of global investigators and service providers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Senhwa BiosciencesTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    10F, No. 225, Sec. 3, Peihsin Rd., Hsintien Dist., New Taipei City 23143
    Telephone
    Telephone
    +886-2-8911-9856
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.senhwabiosciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/senhwa-biosciences
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/senhwabio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Senhwa & BeOne Medicines Ink Deal Targeting Cold Tumors
    Senhwa & BeOne Medicines Ink Deal Targeting Cold Tumors

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/senhwa-biosciences-and-beone-medicines-announces-a-clinical-supply-agreement-to-address-the-challenge-of-cold-tumors-302638027.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    Senhwa Biosciences' Pidnarulex Partners with Global PD-1 Leaders
    Senhwa Biosciences' Pidnarulex Partners with Global PD-1 Leaders

    16 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/senhwa-biosciences-pidnarulex-joins-forces-with-global-pd-1-leaders-to-advance-next-gen-immunotherapy-17800

    INDPHARMAPOST
    16 Sep 2025
    Share Share
    NCI Sponsors Senhwa Second IND for MYC-Aberrant Lymphoma Trial
    NCI Sponsors Senhwa Second IND for MYC-Aberrant Lymphoma Trial

    08 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/us-nci-sponsors-senhwa-biosciences-second-program-ind-submitted-for-clinical-trial-targeting-myc-aberrant-lymphoma-302524102.html

    PR NEWSWIRE
    08 Aug 2025
    Share Share
    First Patient Dosed in Senhwa's NCI-Sponsored Pidnarulex
    First Patient Dosed in Senhwa's NCI-Sponsored Pidnarulex

    15 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/senhwa-biosciences-announces-first-patient-dosed-in-nci-sponsored-pilot-study-of-pidnarulex-cx-5461-pharmacodynamics-in-patients-with-advanced-solid-tumors-302506290.html

    PR NEWSWIRE
    15 Jul 2025
    Share Share
    Senhwa Highlights Dual First-in-Class Drugs at Shareholder Meet
    Senhwa Highlights Dual First-in-Class Drugs at Shareholder Meet

    25 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/senhwa-biosciences-highlights-breakthroughs-in-dual-first-in-class-drug-programs-at-annual-shareholders-meeting-today-302490615.html

    PR NEWSWIRE
    25 Jun 2025
    Share Share
    Senhwa Biosciences Reports Positive Data from Silmitasertib Trial
    Senhwa Biosciences Reports Positive Data from Silmitasertib Trial

    02 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/senhwa-biosciences-announces-positive-clinical-data-from-phase-1expansion-trial-of-silmitasertib-cx-4945-in-the-treatment-of-basal-cell-carcinoma-302418218.html

    PR NEWSWIRE
    02 Apr 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search